
Headache Sciences is a clinical artificial intelligence company focused on pioneering the diagnosis and monitoring of headache disorders, primarily migraine. They leverage machine learning applied to electroencephalography (EEG) to identify subtle biomarkers, aiming to provide objective diagnostic tools. Their business model involves developing 'Software as a Medical Device' (SaMD) and potentially collaborating with pharmaceutical companies as a 'companion diagnostic'. They highlight the potential for improved diagnostics, reduced misdiagnosis, and better patient monitoring, differentiating themselves from traditional drug and medical device companies. They are seeking investors to help commercialize their novel diagnostic test.

Headache Sciences is a clinical artificial intelligence company focused on pioneering the diagnosis and monitoring of headache disorders, primarily migraine. They leverage machine learning applied to electroencephalography (EEG) to identify subtle biomarkers, aiming to provide objective diagnostic tools. Their business model involves developing 'Software as a Medical Device' (SaMD) and potentially collaborating with pharmaceutical companies as a 'companion diagnostic'. They highlight the potential for improved diagnostics, reduced misdiagnosis, and better patient monitoring, differentiating themselves from traditional drug and medical device companies. They are seeking investors to help commercialize their novel diagnostic test.